GH

Guardant Health
NASDAQ

Real-time Quotes | Nasdaq Last Sale

83.22
+0.55
+0.67%
After Hours: 83.87 +0.65 +0.78% 17:11 06/05 EDT
OPEN
83.46
PREV CLOSE
82.67
HIGH
84.52
LOW
81.85
VOLUME
1.14M
TURNOVER
--
52 WEEK HIGH
112.22
52 WEEK LOW
55.90
MARKET CAP
7.87B
P/E (TTM)
-100.3497
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 8 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average GH stock price target is 111.67 with a high estimate of 130.00 and a low estimate of 90.00.

EPS

GH News

More
OncoCyte: Already A Commercial Stage Company With Enormous Revenue Potential
Seeking Alpha - Article · 1d ago
The Daily Biotech Pulse: FDA Nod For Roche's Combo Therapy In Liver Cancer, Allena Rips Higher, Pfizer To Invest Up To $500M In Biotechs
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 1)
Benzinga · 4d ago
Guardant Health prices upsized equity offering at $84
Seeking Alpha - Article · 4d ago
Guardant Health Announces Proposed Public Offering of Common Stock
GlobeNewswire · 5d ago
Guardant Health Announces Proposed Public Offering of Common Stock; 3M Shares Offered By Co. And 7M Offered By SoftBank Investment Advisers
REDWOOD CITY, Calif., June 01, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (NASDAQ:GH) (“Guardant Health”), a leading precision oncology company focused on helping conquer cancer globally through use of
Benzinga · 5d ago
Guardant Health to Participate in the William Blair 2020 Growth Stock Conference
REDWOOD CITY, Calif., May 29, 2020 -- Guardant Health, Inc. (Nasdaq: GH) today announced the company will be participating in the upcoming William Blair Virtual Growth Stock.
GlobeNewswire · 05/29 20:03
Guardant Health: A Rising Star
Seeking Alpha - Article · 05/28 08:55
Guardant Health: Strong Momentum And Enormous Opportunities
Seeking Alpha - Article · 05/24 08:03

Industry

Biotechnology & Medical Research
-0.15%
Pharmaceuticals & Medical Research
+0.37%

Hot Stocks

Symbol
Price
%Change

About GH

Guardant Health, Inc. is a precision oncology company. The Company is focused on helping conquer cancer through use of its blood tests, data sets and analytics. It provides Guardant Health Oncology Platform. It provides liquid biopsy tests, such as Guardant360 and GuardantOMNI, for advanced stage cancer. Its liquid biopsy tests fuels its programs developing tests for recurrence and early detection, LUNAR-1 and LUNAR-2. Guardant360 is a molecular diagnostic test that measures 73 cancer-related genes from circulating tumor deoxyribonucleic acid (ctDNA). Its Guardant360 process includes blood collection, laboratory processing, analysis and reporting. Guardant360 is used for a range of applications, including translational science research and identifying target patient populations, drug development and commercialization post-drug approval.
More

Webull offers kinds of Guardant Health Inc stock information, including NASDAQ:GH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GH stock news, and many more online research tools to help you make informed decisions.